BioWaveHOME
Chronic Pain Management
CommercialActive
Key Facts
About BioWave
BioWave is a commercial-stage medical device company focused on non-invasive, high-frequency peripheral nerve stimulation for pain relief. Its core technology differentiates from superficial TENS units by delivering stimulation deep to the nerve to block pain signal transmission, offering hours of relief post-treatment. With multiple FDA-cleared products (BioWavePRO, HOME, GO, PENS) and a significant contract with the US Veterans Administration, the company targets the large chronic and acute pain markets, emphasizing drug-free alternatives. BioWave operates as a private company, generating revenue through device sales to providers, patients, and institutional partners.
View full company profileTherapeutic Areas
Other Chronic Pain Management Drugs
| Drug | Company | Phase |
|---|---|---|
| Cutaneous Field Stimulation (CFS) Device | Meagan Medical | Pre-clinical/Clinical Research |
| Proclaim XR SCS | Abbott India | Marketed (Global) |